Ultragenyx Pharmaceutical Ownership | Who Owns Ultragenyx Pharmaceutical?
Ultragenyx Pharmaceutical Ownership Summary
Ultragenyx Pharmaceutical is owned by 90.00% institutional investors, 3.62% insiders, and 6.38% retail investors. Vanguard group is the largest institutional shareholder, holding 11.60% of RARE shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 3.03% of its assets in Ultragenyx Pharmaceutical shares.
RARE Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Ultragenyx Pharmaceutical | 90.00% | 3.62% | 6.38% |
| Sector | Healthcare Stocks | 49.73% | 8.84% | 41.43% |
| Industry | Biotech Stocks | 47.04% | 8.74% | 44.21% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Vanguard group | 9.78M | 11.60% | $401.98M |
| Blackrock | 5.60M | 6.65% | $230.30M |
| Sands capital management | 5.35M | 6.35% | $220.08M |
| Wellington management group llp | 4.56M | 5.41% | $187.26M |
| Rtw investments, lp | 3.26M | 3.87% | $133.98M |
| Price t rowe associates inc /md/ | 2.99M | 3.55% | $122.97M |
| State street | 2.70M | 3.20% | $110.85M |
| Clearbridge investments | 2.35M | 2.79% | $96.74M |
| Alkeon capital management | 2.24M | 2.66% | $92.14M |
| Federated hermes | 2.11M | 2.50% | $86.60M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Vestal point capital, lp | 1.80M | 5.52% | $73.98M |
| Cutter capital management, lp | 365.00K | 4.53% | $15.00M |
| Eagle health investments lp | 524.50K | 3.78% | $21.56M |
| First light asset management | 963.15K | 3.47% | $39.59M |
| Suvretta capital management | 2.06M | 3.11% | $84.72M |
| Blue owl capital lp | 268.24K | 3.07% | $11.02M |
| Privium fund management b.v. | 251.60K | 2.63% | $10.31M |
| Bioimpact capital | 380.55K | 2.43% | $15.64M |
| Rock springs capital management lp | 1.92M | 2.38% | $79.08M |
| Rtw investments, lp | 3.26M | 2.07% | $133.98M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Vestal point capital, lp | 1.80M | 5.52% | 1.69M |
| Sands capital management | 5.35M | 0.65% | 1.50M |
| Vanguard group | 9.78M | 0.01% | 1.08M |
| Norges bank | 1.00M | 0.01% | 1.00M |
| Adage capital partners gp | 1.13M | 0.09% | 975.00K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Rtw investments, lp | 3.26M | 2.07% | -3.83M |
| Price t rowe associates inc /md/ | 2.99M | 0.01% | -576.91K |
| Pictet asset management sa | 556.82K | 0.03% | -479.56K |
| Eventide asset management | - | - | -359.00K |
| Mirae asset global investments | 2.48K | 0.00% | -228.28K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Norges bank | 1.00M | 0.01% | 1.00M | $41.20M |
| Frazier life sciences management | 425.00K | 0.82% | 425.00K | $17.47M |
| Cutter capital management, lp | 365.00K | 4.53% | 365.00K | $15.00M |
| D. e. shaw | 203.44K | 0.01% | 203.44K | $8.36M |
| Parkman healthcare partners | 100.00K | 0.55% | 100.00K | $4.11M |
Sold Out
| Holder | Change |
|---|---|
| Mather group, llc. | -2.00 |
| Concourse financial group securities | -3.00 |
| Innealta capital | -15.00 |
| Cibc private wealth group | -19.00 |
| Riggs asset managment | -22.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2024 | 317 | 13.21% | 85,943,715 | -2.53% | 89 | 0.82% | 172 | 4.88% | 93 | 20.78% |
| Jun 30, 2024 | 277 | -0.72% | 88,159,116 | 11.50% | 104 | 1.10% | 163 | 7.95% | 75 | -5.06% |
| Mar 31, 2024 | 279 | 11.16% | 79,067,043 | -1.61% | 97 | 0.78% | 151 | 8.63% | 79 | 3.95% |
| Dec 31, 2023 | 251 | 6.81% | 80,357,498 | 14.79% | 112 | 1.15% | 139 | 19.83% | 76 | 1.33% |
| Sep 30, 2023 | 235 | -7.11% | 70,004,468 | 0.74% | 98 | 1.01% | 116 | -13.43% | 75 | -6.25% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard Total Stock Mkt Idx Inv | 2.79M | 3.03% | -15.66K |
| Sands Capital Select Growth TE Inst EQ | 2.41M | 2.62% | -728.17K |
| Vanguard Small Cap Index | 2.20M | 2.38% | 4.30K |
| Vanguard Explorer Inv | 1.98M | 2.15% | -213.31K |
| Vanguard Institutional Extnd Mkt Idx Tr | 1.37M | 1.49% | -5.15K |
| Hartford MidCap Y | 1.28M | 1.39% | -24.56K |
| Vanguard Small Cap Growth Index Inv | 1.21M | 1.31% | -1.62K |
| DWS Vermögensbildungsfonds I LD | 1.18M | 1.28% | 2.00 |
| Federated Hermes Kaufmann Small Cap Grow | 1.09M | 1.18% | - |
| Federated Hermes Kaufmann Small Cap A | 1.09M | 1.18% | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Dec 10, 2024 | KAKKIS EMIL D | President & CEO | Sell | $413.65K |
| Oct 10, 2024 | Horn Howard | Chief Financial Officer | Sell | $393.85K |
| Sep 03, 2024 | KAKKIS EMIL D | President & CEO | Sell | $1.12M |
| Sep 03, 2024 | Huizenga Theodore Alan | SVP, Chief Accounting Officer | Sell | $5.11K |
| Aug 06, 2024 | KAKKIS EMIL D | President & CEO | Sell | $1.00M |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2024 Q4 | - | 2 |
| 2024 Q3 | - | 4 |
| 2024 Q2 | - | 4 |
| 2024 Q1 | - | 11 |
| 2023 Q4 | - | 3 |
RARE Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools